Login / Signup

Analysis of genotyping for predicting liver injury marker, procollagen III in persons at risk of non-alcoholic fatty liver disease.

Jane I GrovePrarthana ThiagarajanStuart AstburyRebecca HarrisToby DelahookeIndra Neil GuhaGuruprasad Padur Aithal
Published in: Liver international : official journal of the International Association for the Study of the Liver (2018)
Genotyping, therefore, has limited value for predicting severe liver disease in at-risk individuals identified in a community setting.
Keyphrases
  • liver injury
  • drug induced
  • genome wide
  • high throughput
  • healthcare
  • mental health
  • genetic diversity
  • dna methylation
  • gene expression